İlker EYÜBOĞLU, Oğuz DİKBAŞ, Deniz TORUN, İrem İLGEZDİ, Burcu ÜNLÜ

Cerebrotendinous xanthomatosis with a novel mutation in CYP27A1 gene in a Turkish patient

Cerebrotendinous xanthomatosis (CTX) is a rare genetic metabolic disorder that inherited in an autosomal recessive trait;characterized by abnormal lipid storage. CTX is characterized by infantile or early childhood onset of chronic diarrhea, tendonxanthomas (especially in the achilles tendon), cataracts, and neurological symptoms such as cognitive impairment, pyramidal,extrapyramidal and cerebellar signs, seizures, peripheral neuropathy that appear in the second or third decades of life. A thirtynine years old Turkish female patient admitted to the Neurology outpatient clinic with the complaint of increasing dizziness andwalking difficulty in recent years. She had an operation for both achilles tendon xanthomas and juvenile cataract. Her neurologicalsymptoms and cranial magnetic resonance imaging (MRI) findings were consistent with cerebrotendinous xanthomatosis. A novelhomozygous splicing site mutation (IVS8+2T>C, c.1476+2T>C, NM_000784.3) in CYP27A1 gene was detected. This is the first CTXrelated mutation reported in the literature.

PDF

___

1. Degos B, Nadjar Y, Amador Mdel M, et al. Natural history of cerebrotendinous xanthomatosis: a paediatric disease diagnosed in adulthood. Orphanet J Rare Dis 2016;11:41.
2. Nie S, Chen G, Cao X, et al. Cerebrotendinous xanthomatosis: a comprehensive review of pathogenesis, clinical manifestations, diagnosis, and management. Orphanet J Rare Dis 2014;9:179.
3. Salen G, Steiner RD. Epidemiology, diagnosis, and treatment of cerebrotendinous xanthomatosis (CTX). J Inherit Metab Dis 2017;40:771–81.
4. Verrips A, van Engelen BG, Wevers RA, et al. Presence of diarrhea and absence of tendon xanthomas in patients with cerebrotendinous xanthomatosis. Arch Neurol 2000;57:520–4.
5. Mignarri A, Gallus GN, Dotti MT, et al. A suspicion index for early diagnosis and treatment of cerebrotendinous xanthomatosis. J Inherit Metab Dis 2014;37:421-9.
6. Lorbek G, Lewinska M, Rozman D. Cytochrome P450s in the synthesis of cholesterol and bile acidsfrom mouse models to human diseases.The FEBS J 2012;279:1516-33.
7. Gallus G, Dotti MT,Federico A. Clinical and molecular diagnosis of cerebrotendinous xanthomatosis with a review of the mutations in the CYP27A1 gene. Neurol Sci 2006;27:143-9.
8. Zubarioglu T, Kiykim E,Yesil G, et al. Early diagnosed cerebrotendinous xanthomatosis patients: clinical, neuroradiological characteristics and therapy results of a single center from Turkey. Acta Neurol Belg 2019;119:343-50.